Source: ERS webinar 2021: Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Blum (Berlin, Germany), J. Cadranel (Paris, France), D. Jovanovic (Belgrade, Serbia). Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases. ERS webinar 2021: Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases

Member's Comments

No comment yet.

Related content which might interest you: Current challenges in the management of nonsmall cell lung cancer brain metastases Source: Eur Respir J, 55 (1) 1901686; 10.1183/13993003.01686-2019 Year: 2020 Management of brain metastases in patients with non-small cell lung cancer Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Do cavitating non-small cell lung cancer patients have a more aggressive disease? Source: Eur Respir J 2006; 28: Suppl. 50, 84s Year: 2006 Multimodal management of brain metastases in lung cancer Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Efficacy of a pulmonary rehabilitation programme (PRP) after lung resection (LR) for cancer Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention Year: 2005 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Treatment choices in lung cancer patients with brain metastasis Source: Eur Respir J 2001; 18: Suppl. 33, 378s Year: 2001 Treatment modalities in lung cancer patients with brain metastasis Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012 Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010 Brain metastases in lung cancer patients Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients. Year: 2019 Pulmonary re-biopsy in non–small-cell lung cancer (NSCLC) locally advanced or metastatic  with EGFR-T790M resistance. Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound Year: 2018 Detecting extrathoracic metastases in patients with non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 41s Year: 2006 Metastatic disease in non-small cell lung cancer: is it all the same? Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Challenges in the management of SCLC Source: ERS webinar 2021: Challenges in the management of SCLC Year: 2021 Lung cancer: does age affect treatment strategy? Source: Eur Respir Mon; 2009: 43:306–326 Year: 2009 Lung cancer Source: Respipedia Article Year: 2018 Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019